Skip to main content
All lobbying filings

T1INTERNATIONAL USA

Lobbying for T1INTERNATIONAL USA

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Maine · House · Senate · posted Jul 15, 2026

Official filing document

 Bills named in this filing 1
 Lobbying activity 1
Health Issues

Issues related to the following bills: oAffordable Drug Manufacturing Act (no bill number yet) - To establish an Office of Drug Manufacturing within HHS and for them to manufacture generic drugs that the federal government has licensed. oS.4189: INSULIN Act - To reduce the price of insulin and provide for patient protections with respect to the cost of insulin. oH.R.3269/S.2276: ETHIC Act - would curb the practice of patent thicketing, bringing competition to the domestic biosimilars market and increasing access to lower cost treatments and cures.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem